AMSTERDAM (dpa-AFX) - Royal Philips (PHG) announced its next-generation
AI-enabled cardiovascular ultrasound platform to help speed up cardiac
ultrasound analysis with AI technology. Integrated into the EPIQ CVx and
Affiniti CVx ultrasound systems, the new FDA 510(k) cleared AI applications
significantly advance Philips' cardiovascular imaging and diagnosis solutions.

The company noted that the AI features automate how users interpret ultrasound
images, so clinicians with varying levels of ultrasound experience can
automatically analyze images with increased speed, efficiency, and accuracy in
real time.

For More Such Health News, visit rttnews.com.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX